Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 3841 AL 3855

Cross cultural adaptations and psychometric domains of Brazilian version of PROFILE PD for Parkinson's disease

Swarowsky A, Fontana SRCB, Santos MP, Silva BAD, Spagnuolo G, Ovando AC, Ilha J.

Disabil Rehabil. 2017 Aug;39(17):1759-1770. doi: 10.1080/09638288.2016.1209695. Epub 2016 Aug 16.

Thoughts on fatigue in Parkinson's disease (and other disorders)

Friedman JH.

Eur J Neurol. 2017 Jan;24(1):5-6. doi: 10.1111/ene.13168. Epub 2016 Oct 4.

PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease

Arena G, Valente EM.

J Pathol. 2017 Jan;241(2):251-263. doi: 10.1002/path.4815. Epub 2016 Nov 12.

Exercise to prevent falls in older adults: an updated systematic review and meta-analysis

Sherrington C, Michaleff ZA, Fairhall N, Paul SS, Tiedemann A, Whitney J, Cumming RG, Herbert RD, Close JCT, Lord SR.

Br J Sports Med. 2017 Dec;51(24):1750-1758. doi: 10.1136/bjsports-2016-096547. Epub 2016 Oct 4.

Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis

Hirata FCC, Sato JR, Vieira G, Lucato LT, Leite CC, Bor-Seng-Shu E, Pastorello BF, Otaduy MCG, Chaim KT, Campanholo KR, Novaes NP, Melo LM, Gonçalves MR, do Nascimento FBP, Teixeira MJ, Barbosa ER, Amaro E Jr, Cardoso EF.

Eur Radiol. 2017 Jun;27(6):2640-2648. doi: 10.1007/s00330-016-4611-0. Epub 2016 Oct 5.

An Overview of Analytical Methods for the Determination of Monoamine Oxidase Inhibitors in Pharmaceutical Formulations and Biological Fluids

Saka C.

Crit Rev Anal Chem. 2017 Jan 2;47(1):1-23. doi: 10.1080/10408347.2014.964835. Epub 2016 Oct 7.

A single dose of L-DOPA changes perceptual experiences and decreases latent inhibition in Parkinson's disease

Györfi O, Nagy H, Bokor M, Kelemen O, Kéri S.

J Neural Transm (Vienna). 2017 Jan;124(1):113-119. doi: 10.1007/s00702-016-1630-6. Epub 2016 Oct 7.

Pesticides: an update of human exposure and toxicity

Mostafalou S, Abdollahi M.

Arch Toxicol. 2017 Feb;91(2):549-599. doi: 10.1007/s00204-016-1849-x. Epub 2016 Oct 8.

Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease

Shohet A, Khlebtovsky A, Roizen N, Roditi Y, Djaldetti R.

Eur J Pain. 2017 Mar;21(3):486-493. doi: 10.1002/ejp.942. Epub 2016 Oct 10.

Leucine-rich repeat kinase 2 and Parkinson's disease

Kang UB, Marto JA.

Proteomics. 2017 Jan;17(1-2). doi: 10.1002/pmic.201600092. Epub 2016 Dec 21.

An observational clinical and video-polysomnographic study of the effects of rotigotine in sleep disorder in Parkinson's disease

Wang Y, Yang YC, Lan DM, Wu H-, Zhao ZX.

Sleep Breath. 2017 May;21(2):319-325. doi: 10.1007/s11325-016-1414-0. Epub 2016 Oct 11.

An Unusual Case of Alternating Ventricular Morphology on the 12-Lead Electrocardiogram

Sammon M, Dawood A, Beaudoin S, Harrigan RA.

J Emerg Med. 2017 Mar;52(3):348-353. doi: 10.1016/j.jemermed.2016.08.027. Epub 2016 Oct 7.

Subthalamic Nucleus Deep Brain Stimulation Alters Prefrontal Correlates of Emotion Induction

Bick SK, Folley BS, Mayer JS, Park S, Charles PD, Camalier CR, Pallavaram S, Konrad PE, Neimat JS.

Neuromodulation. 2017 Apr;20(3):233-237. doi: 10.1111/ner.12537. Epub 2016 Oct 12.

Validation of the National Institute of Neurological Disorders and Stroke Criteria for Psychosis in Parkinson Disease

Gordon PC, Rocha MS, Kauark RG, Costa CD, de Oliveira MO, Godinho F, Borges V.

Am J Geriatr Psychiatry. 2017 Jan;25(1):73-80. doi: 10.1016/j.jagp.2016.08.011. Epub 2016 Aug 26.

Preserved ability to cycle in patient with progressive supranuclear palsy-parkinsonism

Bažadona D, Miletić V.

Neurol Sci. 2017 Mar;38(3):509-510. doi: 10.1007/s10072-016-2735-2. Epub 2016 Oct 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias